Javascript must be enabled to continue!
Thoughts on the diversity of convergent evolution of bioluminescence on earth
View through CrossRef
AbstractThe widespread independent evolution of analogous bioluminescent systems is one of the most impressive and diverse examples of convergent evolution on earth. There are roughly 30 extant bioluminescent systems that have evolved independently on Earth, with each system likely having unique enzymes responsible for catalysing the bioluminescent reaction. Bioluminescence is a chemical reaction involving a luciferin molecule and a luciferase or photoprotein that results in the emission of light. Some independent systems utilize the same luciferin, such as the use of tetrapyrrolic compounds by krill and dinoflagellates, and the wide use of coelenterazine by marine organisms, while the enzymes involved are unique. One common thread among all the different bioluminescent systems is the requirement of molecular oxygen. Bioluminescence is found in most forms of life, especially marine organisms.Bioluminescence in known to benefit the organism by: attraction, repulsion, communication, camouflage, and illumination. The marine ecosystem is significantly affected by bioluminescence, the only light found in the pelagic zone and below is from bioluminescent organisms.Transgenic bioluminescent organisms have revolutionized molecular research, medicine and the biotechnology industry. The use of bioluminescence in studying molecular pathways and disease allows for non-invasive and real-time analysis. Bioluminescence-based assays have been developed for several analytes by coupling luminescence to many enzyme-catalysed reactions.
Cambridge University Press (CUP)
Title: Thoughts on the diversity of convergent evolution of bioluminescence on earth
Description:
AbstractThe widespread independent evolution of analogous bioluminescent systems is one of the most impressive and diverse examples of convergent evolution on earth.
There are roughly 30 extant bioluminescent systems that have evolved independently on Earth, with each system likely having unique enzymes responsible for catalysing the bioluminescent reaction.
Bioluminescence is a chemical reaction involving a luciferin molecule and a luciferase or photoprotein that results in the emission of light.
Some independent systems utilize the same luciferin, such as the use of tetrapyrrolic compounds by krill and dinoflagellates, and the wide use of coelenterazine by marine organisms, while the enzymes involved are unique.
One common thread among all the different bioluminescent systems is the requirement of molecular oxygen.
Bioluminescence is found in most forms of life, especially marine organisms.
Bioluminescence in known to benefit the organism by: attraction, repulsion, communication, camouflage, and illumination.
The marine ecosystem is significantly affected by bioluminescence, the only light found in the pelagic zone and below is from bioluminescent organisms.
Transgenic bioluminescent organisms have revolutionized molecular research, medicine and the biotechnology industry.
The use of bioluminescence in studying molecular pathways and disease allows for non-invasive and real-time analysis.
Bioluminescence-based assays have been developed for several analytes by coupling luminescence to many enzyme-catalysed reactions.
Related Results
Theia can arrive late and be oxidized, but not if it is large compared to proto-Earth
Theia can arrive late and be oxidized, but not if it is large compared to proto-Earth
The Moon-forming impact was the most significant event during the accretion of Earth substantially establishing the physical and chemical states of the Earth-Moon system. In the ca...
A bright synthetic near-infrared luciferin enhances the capabilities of deep-tissue bioluminescence imaging using firefly luciferases
A bright synthetic near-infrared luciferin enhances the capabilities of deep-tissue bioluminescence imaging using firefly luciferases
Abstract
Synthetic bioluminescence reactions exhibiting near-infrared (NIR)-shifted spectra have been explored to improve deep-tissue imaging through the design of firefly ...
Analysis, quantification and identification of in situ bioluminescence signals by an innovative sensor (CEMSOR2)
Analysis, quantification and identification of in situ bioluminescence signals by an innovative sensor (CEMSOR2)
Bioluminescence, the light emitted naturally by marine organisms, is the main light source in the mesopelagic zone. Nearly 75% of marine organisms, from the surface to the deep sea...
Reporting amyloid beta levels
via
bioluminescence imaging with amyloid reservoirs in Alzheimer’s disease models
Reporting amyloid beta levels
via
bioluminescence imaging with amyloid reservoirs in Alzheimer’s disease models
Abstract
Bioluminescence imaging has changed daily practice in preclinical research of cancers and other diseases in the last decades; however, i...
Aligning functional network constraint to evolutionary outcomes
Aligning functional network constraint to evolutionary outcomes
Summary
It is likely that there are constraints on how evolution can progress, and well-known evolutionary phenomena such as convergent evolution, rapid adaptation,...
Convergent transcriptomic and genomic adaptation in xeric rodents
Convergent transcriptomic and genomic adaptation in xeric rodents
ABSTRACT
Repeated adaptations rely in part on convergent genetic changes. The extent of convergent changes at the genomic scale is debated and may depend on the int...
An Investigation on the Determination of Compressive Strength of Poured-earth/Earth-cobs (PEEC) Masonry Wall
An Investigation on the Determination of Compressive Strength of Poured-earth/Earth-cobs (PEEC) Masonry Wall
Excessive shrinkage as the cause of low compressive strength associated with the monolithic poured earth method of earth construction is always a discouraging factor for profession...
Abstract 1832: Bioluminescent pharmacokinetics of luciferin in preclinical brain metastases of breast cancer models
Abstract 1832: Bioluminescent pharmacokinetics of luciferin in preclinical brain metastases of breast cancer models
Abstract
Background: Approximately 20% of breast cancer patients with disseminated disease will develop brain metastases. Preclinical models of brain metastases of b...

